Synaptogenix

1 follower


Discovering restorative, novel therapeutics for patients with life altering neurodegenerative diseases and developmental disorders.

Industries

Employees

Links

Alan Tuchman
Chief Executive Officer

Alan Tuchman

Collapse
Daniel L. Alkon
President & Chief Science Officer
Robert Weinstein
Chief Financial Officer
Elaine Grenier
Executive Director, Clinical Ops